Pharmacology

Reduction of Thrombus Burden With Short‐Term, Low‐Dose Rivaroxaban Use in Acute Myocardial Infarction: The ARISE‐ARMYDA 7 Randomized Trial Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes? Empagliflozin Improves Cardiomyocyte Function in Phospholamban‐R14del Cardiomyopathy by Regulating Calcium/Calmodulin‐Stimulated Protein Kinase II Activity and Apoptosis Letter by Kornelius Regarding Article, “Cardiovascular Disease in Anabolic Androgenic Steroid Users” Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES Registry 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation Renal Denervation for the Treatment of Hypertension Advances in the Detection and Management of Vulnerable Coronary Plaques Response by Bulluck and Hausenloy to Letter Regarding Article, “Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)”